Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: DeLong Mark Jeffrey, officer

Transaction date: Jan. 13, 2026

Reporting date: Jan. 15, 2026

Average share price: 22.1872

Sold 1780.0 shares for 39493.22